Genomics :: Governance, Ethics, Policy, Practice – A Monthly Digest
May 2025 :: Number 15
Genomics – spanning discovery, preclinical, clinical and translation to daily patient interventions – continues to evolve at an extraordinary pace. Advances in the scientific and technical dimensions of genomics overall are extensively communicated through the peer-reviewed journal literature and supporting grey literature.
Complementing this technical literature is a growing body of research, analysis and commentary addressing the governance, ethics, regulation, and policy dimensions of areas including genomic medicine. Much of this content is communicated through academic journals and grey literature. This digest intends to capture and curate the most substantive examples of this non-technical content.
Further, we intend this digest to provide a useful summary of key strategic and programmatic announcements from across genomics as issued by multilateral agencies, INGOs, governments/regulatory bodies, academic and research institutions, consortia and collaborations, foundations, investors, and commercial organizations.
Given the complexity and velocity of the field, we recognize that this digest will be indicative, not exhaustive. We invite suggestions and ideas on how it can evolve to be more useful.
The digest is a program of the GE2P2 Global Foundation which is solely responsible for its content. Questions and comments should be directed to the editor: david.r.curry@ge2p2global.org o
Center for Genomic Medicine Governance, Ethics & Policy 